CONVERSION OF 5-FLUOROCYTOSINE TO 5-FLUOROURACIL BY HUMAN INTESTINAL MICROFLORA

被引:86
作者
HARRIS, BE
MANNING, BW
FEDERLE, TW
DIASIO, RB
机构
[1] UNIV ALABAMA, DEPT PHARMACOL, DIV CLIN PHARMACOL, BIRMINGHAM, AL 35294 USA
[2] UNIV ALABAMA, DEPT MED, BIRMINGHAM, AL 35294 USA
[3] UNIV ALABAMA, DEPT BIOL, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1128/AAC.29.1.44
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:44 / 48
页数:5
相关论文
共 22 条
[1]   FLUCYTOSINE [J].
BENNETT, JE .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (03) :319-322
[2]   COMPARISON OF AMPHOTERICIN-B ALONE AND COMBINED WITH FLUCYTOSINE IN THE TREATMENT OF CRYPTOCCAL MENINGITIS [J].
BENNETT, JE ;
DISMUKES, WE ;
DUMA, RJ ;
MEDOFF, G ;
SANDE, MA ;
GALLIS, H ;
LEONARD, J ;
FIELDS, BT ;
BRADSHAW, M ;
HAYWOOD, H ;
MCGEE, ZA ;
CATE, TR ;
COBBS, CG ;
WARNER, JF ;
ALLING, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (03) :126-131
[3]   DETERMINATION OF ORGANIC-ACIDS OF LOW RELATIVE MOLECULAR MASS (C1 TO C4) IN DILUTE AQUEOUS-SOLUTION [J].
BETHGE, PO ;
LINDSTRO.K .
ANALYST, 1974, 99 (1175) :137-142
[4]   EXPERIMENTAL THERAPY OF CLADOSPORIOSIS AND SPOROTRICHOSIS WITH 5-FLUOROCYTOSINE [J].
BLOCK, ER ;
IJENNING.AE ;
BENNETT, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (01) :95-98
[5]   EFFECT OF MEAT PROTEIN AND DIETARY FIBER ON COLONIC FUNCTION AND METABOLISM .2. BACTERIAL METABOLITES IN FECES AND URINE [J].
CUMMINGS, JH ;
HILL, MJ ;
BONE, ES ;
BRANCH, WJ ;
JENKINS, DJA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (10) :2094-2101
[6]   EVIDENCE FOR CONVERSION OF 5-FLUOROCYTOSINE TO 5-FLUOROURACIL IN HUMANS - POSSIBLE FACTOR IN 5-FLUOROCYTOSINE CLINICAL TOXICITY [J].
DIASIO, RB ;
LAKINGS, DE ;
BENNETT, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (06) :903-908
[7]  
DUBOS R, 1963, FED PROC, V22, P1322
[8]  
FINCH RE, 1979, BRIT J CLIN PHARMACO, V7, P613, DOI 10.1111/j.1365-2125.1979.tb04651.x
[9]   BIOCHEMICAL PHARMACOLOGY OF INTESTINAL FLORA [J].
GOLDMAN, P .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1978, 18 :523-539
[10]  
HEIDELBERGER C, 1982, CANCER MED, P801